Literature DB >> 74982

[Concentration of intravenously administered gammaglobulin preparations in dog skin (author's transl)].

J Ring, K H Duswald, T Bachmann, W Stephan, W Brendel.   

Abstract

Chemical modification of standard gammaglobulin with enzyme treatment (pepsin) or stabilization (beta-propiolactone) is able to influence elimination, fragmentation and organ distribution of intravenously administered gammaglobulins as shown in 36 dogs after i.v. application of allogenic and xenogenic gammaglobulin preparations. Pepsin-gammaglobulin was eliminated and fragmented most rapidly. Gammaglobulin concentrations of all preparations in the skin showed as slower decrease than comparable blood concentrations. The highest skin concentrations 10 days after i.v. application were found for beta-propiolactone gammaglobulin with 6.2 +/- 1.6 microgram/g compared to a blood level of 7.9 +/- 0.9 microgram/ml.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 74982     DOI: 10.1007/BF00561414

Source DB:  PubMed          Journal:  Arch Dermatol Res            Impact factor:   3.017


  17 in total

Review 1.  [GAMMA GLOBULIN THERAPY. CHEMICAL, IMMUNOLOGICAL AND CLINICAL PRINCIPLES].

Authors:  S BARANDUN
Journal:  Bibl Haematol       Date:  1964

2.  Studies of aggregated gamma-globulin. I. Sedimentation, electrophoretic and anticomplementary properties.

Authors:  C L CHRISTIAN
Journal:  J Immunol       Date:  1960-01       Impact factor: 5.422

3.  The isolation of gamma globulin from blood-serum by rivanol.

Authors:  J HOREJSI; R SMETANA
Journal:  Acta Med Scand       Date:  1956-06-30

4.  Turnover of standard-gammaglobulin, pH-4-gammaglobulin and pepsin desaggregated gammaglobulin and clinical implications.

Authors:  H Koblet; S Barandun; H Diggelmann
Journal:  Vox Sang       Date:  1967-07       Impact factor: 2.144

5.  [Experimental tests on animals concerning the question of passive immunity by means of intravenously administered immunoglobulin preparations. I. Studies of mice with sublethal staphylococcus infection (author's transl)].

Authors:  P S Tata; E Werner
Journal:  Res Exp Med (Berl)       Date:  1974

6.  [Elimination of complement fixation of gamma-globulin by chemical modification with beta-propiolactone].

Authors:  W Stephan
Journal:  Z Klin Chem Klin Biochem       Date:  1969-05

7.  Undegraded human immunoglobulin for intravenous use.

Authors:  W Stephan
Journal:  Vox Sang       Date:  1975       Impact factor: 2.144

8.  Anaphylactoid reactions due to non-immune complex serum protein aggregates.

Authors:  J Ring; J Seifert; F Jesch; W Brendel
Journal:  Monogr Allergy       Date:  1977

9.  [Cure of a widespread eczema herpeticatum in generalized neurodermatitis with Gamma-Venin].

Authors:  I Hiemisch
Journal:  Hautarzt       Date:  1970-11       Impact factor: 0.751

10.  Clinical tolerance and catabolism of plasmin-treated gamma-globulin for intravenous application.

Authors:  S Barandun; V Castel; M F Makula; A Morell; R Plan; F Skvaril
Journal:  Vox Sang       Date:  1975       Impact factor: 2.144

View more
  2 in total

1.  Efficacy of intravenous immunoglobulin preparations against viral and bacterial infections in mouse protection tests.

Authors:  W Stephan; H Dichtelmüller
Journal:  Infection       Date:  1983 Jul-Aug       Impact factor: 3.553

2.  [Problems of intravenous gammaglobulin therapy (author's transl)].

Authors:  J Ring; K H Duswald
Journal:  Klin Wochenschr       Date:  1980-08-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.